# FDA Inspection 608851 - Janusz Rolski, M.D., PhD. Klinika Klinika Nowotworow - August 14, 2009

Source: https://www.globalkeysolutions.net/records/fda_inspections/janusz-rolski-md-phd-klinika-klinika-nowotworow/f972cd25-20df-4cc1-b817-611c3dd764d0/
Source feed: FDA_Inspections

> FDA Inspection 608851 for Janusz Rolski, M.D., PhD. Klinika Klinika Nowotworow on August 14, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 608851
- Company Name: Janusz Rolski, M.D., PhD. Klinika Klinika Nowotworow
- Inspection Date: 2009-08-14
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 587305 - 2009-05-15](https://www.globalkeysolutions.net/api/records/fda_inspections/janusz-rolski-md-phd-klinika-klinika-nowotworow/0883663e-4d3c-4f27-9e05-cba313a2234b/)

Company: https://www.globalkeysolutions.net/companies/janusz-rolski-md-phd-klinika-klinika-nowotworow/ce6a191b-1f51-4df3-b18a-65bd811838a0

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c